Flexion Therapeutics Inc Revenue per Employee (FLXN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Flexion Therapeutics Inc   (NASDAQ: FLXN)
 

Flexion Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Flexion Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 466,977, but the productivity of Flexion Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 38 other companies have achieved higher revenue per employee. While Flexion Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 927. Flexion Therapeutics Inc has 215 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FLXN Revenue per Employee (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Revenue Change -9.88 % 82.35 % 22.17 % 11.23 % 8.62 %
Sales per Employee (TTM) $ 466,977 477,851 418,670 397,916 385,563
FLXN's Total Ranking # 927 # 0 # 0 # 0 # 0
Seq. Revenue Change -24.31 % 14.58 % -6.54 % 11.18 % 53.16 %

FLXN Company Profile >> Back to FLXN Efficiency Comparisons >> Compare FLXN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 39
Overall Market # 927

Revenue per Employee Statistics
High Average Low
$ 477,851 $ 372,554 $ 204,884
(Jun 30 2021)   (Jun 30 2019)



Financial Statements
Flexion Therapeutics Inc 's Revenue MRQ $ 21 Millions Visit FLXN's Income Statement
Flexion Therapeutics Inc 's Revenues TTM $ 100 Millions Visit FLXN's aggregate revenue growth
What are FLXN's Sales? Visit FLXN's Sales by Segment




Other Ratios
Flexion Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FLXN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FLXN's Competitors
Revenue per Employee for FLXN's Suppliers
Revenue per Employee for FLXN's Customers

You may also want to know
FLXN's Sales Growth Rates FLXN's Pe Price to earnings ratio FLXN's Receivables Turnover Ratio FLXN's Stock Quote
FLXN's Net Income Growth Rates FLXN's Ps Price to Sales ratio FLXN's Sales per Employee FLXN's Asset Turnover Ratio
FLXN's Net Margin FLXN's Pb Price to Book ratio FLXN's Financial Strength Ratios FLXN's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:25+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2021Number of Employees Sep 30 2021
Enanta Pharmaceuticals Inc  808,950.00 $ 97.074  Million 120 
Retractable Technologies Inc  800,607.18 $ 160.922  Million 201 
Vir Biotechnology Inc   774,915.53 $ 284.394  Million 367 
Sarepta Therapeutics Inc   773,130.54 $ 645.564  Million 835 
Fulgent Genetics Inc   770,752.23 $ 1,035.891  Million 1,344 
G1 Therapeutics Inc   767,745.45 $ 42.226  Million 55 
Ngm Biopharmaceuticals Inc   766,900.00 $ 76.690  Million 100 
Sangamo Therapeutics Inc   764,190.14 $ 108.515  Million 142 
Carlisle Companies Incorporated  762,440.68 $ 4,498.400  Million 5,900 
Reshape Lifesciences Inc  759,111.11 $ 13.664  Million 18 
Hologic Inc  746,478.08 $ 5,277.600  Million 7,070 
Phenomex Inc   736,403.51 $ 83.950  Million 114 
Adamas Pharmaceuticals Inc  734,908.33 $ 88.189  Million 120 
Catalyst Pharmaceuticals Inc   733,730.27 $ 133.539  Million 182 
Emmaus Life Sciences Inc   722,484.85 $ 23.842  Million 33 
Wearable Health Solutions, Inc.  712,750.00 $ 1.425  Million 2 
Cerus Corporation  710,194.44 $ 204.536  Million 288 
Hookipa Pharma inc   704,142.86 $ 19.716  Million 28 
Denali Therapeutics Inc   701,713.72 $ 352.962  Million 503 
Spero Therapeutics Inc   696,760.00 $ 17.419  Million 25 
Shockwave Medical Inc   694,383.40 $ 175.679  Million 253 
Aim Immunotech Inc   687,190.48 $ 14.431  Million 21 
Alpha Pro Tech Ltd   686,674.80 $ 84.461  Million 123 
Heron Therapeutics Inc   674,187.50 $ 86.296  Million 128 
Theravance Biopharma inc   656,611.11 $ 59.095  Million 90 
Johnson and Johnson  649,474.43 $ 91,446.000  Million 140,800 
Precigen Inc   645,218.75 $ 103.235  Million 160 
Milestone Scientific Inc   644,716.27 $ 9.671  Million 15 
Vapotherm Inc   643,682.93 $ 131.955  Million 205 
Merck and Co Inc   635,960.00 $ 47,697.000  Million 75,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.